Items where Author is "Ajib, Salem"
![]() | Up a level |
Article
Penack, Olaf and Dreger, Peter and Ajib, Salem and Ayuk, Francis and Baermann, Ben-Niklas and Bug, Gesine and Kriege, Oliver and Jentzsch, Madlen and Kobbe, Guido and Koenecke, Christian and Lutz, Mathias and Martin, Sonja and Schlegel, Paul-Gerhard and Schroers, Roland and von Tresckow, Bastian and Vucinic, Vladan and Subklewe, Marion and Bethge, Wolfgang and Wolff, Daniel (2024) Management of Patients Undergoing CAR-T Cell Therapy in Germany. ONCOLOGY RESEARCH AND TREATMENT, 47 (3). ISSN 2296-5270, 2296-5262
Schuler, Esther and Wagner-Drouet, Eva-Maria and Ajib, Salem and Bug, Gesine and Crysandt, Martina and Dressler, Sabine and Hausmann, Andreas and Heidenreich, Daniela and Hirschbuehl, Klaus and Hoepting, Matthias and Jost, Edgar and Kaivers, Jennifer and Klein, Stefan and Koldehoff, Michael and Kordelas, Lambros and Kriege, Oliver and Mueller, Lutz P. and Rautenberg, Christina and Schaffrath, Judith and Schmid, Christoph and Wolff, Daniel and Haas, Rainer and Bornhaeuser, Martin and Schroeder, Thomas and Kobbe, Guido (2021) Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group. ANNALS OF HEMATOLOGY, 100. pp. 959-968. ISSN 0939-5555, 1432-0584
Conference or Workshop Item
Schuler, Esther and Wagner-Drouet, Eva-Maria and Ajib, Salem and Bug, Gesine and Crysandt, Martina and Dressler, Sabine and Hausmann, Andreas and Heidenreich, Daniela and Hirschbuehl, Klaus and Hoepting, Matthias and Jost, Edgar and Kaivers, Jennifer and Klein, Stefan and Kordelas, Lambros and Kriege, Oliver and Mueller, Lutz and Rautenberg, Christina and Schaffrath, Judith and Schmid, Christoph and Wolff, Daniel and Haas, Rainer and Bornhaeuser, Martin and Schroeder, Thomas and Kobbe, Guido (2020) Venetoclax, Hypomethylating Agents and Dli for Salvage Treatment of Myeloid Malignancies Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation. In: 46th Annual Meeting of the EBMT, 29 August - 1 September, 2020, Virtuell.

